Humanin Nasal Spray

Direct Anti Peptide offers Humanin Nasal Spray at ≥98% purity, produced under rigorous quality control standards and intended exclusively for qualified research professionals and laboratory settings. This nasal spray formulation represents a convenient and stable delivery format for researchers investigating mitochondrial biology, neuroprotection, and metabolic function at the cellular level.

Product Overview

Humanin is a small bioactive peptide originally identified as being encoded within the mitochondrial genome. It has attracted substantial interest in the life sciences research community for its potential roles in cytoprotection, energy metabolism, and age-related cellular decline. Available as a ready-to-use nasal spray solution from Direct Anti Peptide, this product is designed to support advanced in vitro and preclinical research workflows requiring a stable, precisely formulated peptide vehicle.

Peptide Structure & Amino Acid Sequence

Humanin is a 21-amino acid peptide with the sequence MAPRGFSCLLLLTSEIDLPVKRRA in its full mitochondrial open reading frame-derived form, though the biologically active core sequence commonly referenced in research is CIGAQLNPQHALDEFEIHLQKAK (21 residues). Its compact structure contributes to its notable stability and receptor-binding specificity. The peptide interacts with several receptor systems, including formyl peptide receptor-like 1 (FPRL1) and gp130, which are implicated in cell survival signaling pathways studied in neurological and metabolic research contexts.

Chemical & Physical Characteristics

• Peptide Origin: Mitochondrial genome-derived
• Length: 21 amino acids
• Molecular Weight: Approximately 2,887 Da
• Formulation: Aqueous nasal spray solution
• Appearance: Clear, colorless to pale solution
• Purity: ≥98% by HPLC analysis
• Storage Condition: 2–8°C (refrigerated); protect from light and repeated freeze-thaw cycles

Purity & Analytical Verification (HPLC & MS)

Every batch of Humanin Nasal Spray supplied by Direct Anti Peptide is analytically verified to meet a minimum purity threshold of ≥98%. High-performance liquid chromatography (HPLC) is employed to confirm peptide purity and homogeneity, while mass spectrometry (MS) is used to verify molecular identity and confirm the absence of truncated sequences or synthetic by-products. Certificates of Analysis (CoA) are available upon request and accompany each order, providing full traceability and batch-level documentation for laboratory compliance records.

Quality Control & Lyophilization Integrity

Where applicable, Humanin peptide components undergo lyophilization under controlled conditions prior to formulation into the nasal spray vehicle. This process preserves peptide integrity, minimizes degradation, and ensures consistent potency across batches. The final spray formulation is tested for pH stability, particulate absence, and peptide concentration uniformity before release. Direct Anti Peptide maintains strict internal quality benchmarks to ensure that every unit shipped meets the highest standards expected by research institutions and laboratory procurement teams.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for trained research professionals operating within properly equipped laboratory environments. Standard laboratory safety practices must be observed at all times, including the use of appropriate personal protective equipment (PPE) such as gloves, lab coats, and eye protection. Researchers should consult applicable institutional biosafety guidelines and safety data sheets before handling. This product is not approved for human or animal administration and must never be used in clinical, therapeutic, diagnostic, or consumptive contexts.

Reconstitution, Packaging & Storage

Humanin Nasal Spray is supplied in a ready-to-use spray bottle format, eliminating the need for reconstitution in most research applications. The product should be stored at 2–8°C upon receipt and kept away from direct light sources. Researchers should avoid repeated temperature cycling to preserve peptide stability. The spray mechanism is designed for precise, reproducible volumetric delivery in controlled laboratory assay conditions. Packaging is tamper-evident and clearly labeled with batch number, purity, and research-use-only designation.

Intended Research Use & Market Positioning

Humanin Nasal Spray is positioned for use in preclinical and in vitro research programs focused on mitochondrial biology, neuroprotection, metabolic health modulation, cardiovascular cellular research, and age-related cellular physiology. Research literature has explored Humanin’s interactions with pathways relevant to neurodegeneration, insulin signaling, and oxidative stress response. Direct Anti Peptide supplies this compound to academic institutions, biotech research teams, and independent laboratories seeking a reliable, high-purity source of this mitochondria-derived peptide for sale at a competitive price.

Ordering, Availability & Fulfillment

Humanin Nasal Spray is available to buy online now through Direct Anti Peptide with fast order processing and reliable international fulfillment. We offer competitive best-price guarantees on all research peptides, with secure checkout and discreet, research-compliant packaging. Orders are dispatched promptly following verification, and our customer support team is available to assist with bulk inquiries, institutional purchase orders, and CoA requests. Order now to secure your supply of this in-demand mitochondrial research peptide.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Humanin Nasal Spray sold by Direct Anti Peptide is strictly intended for qualified scientific research conducted by trained professionals in licensed laboratory settings. It is the sole responsibility of the purchaser to ensure compliance with all applicable local, national, and international regulations governing the procurement, handling, and use of research peptides. Direct Anti Peptide assumes no liability for misuse, improper handling, or use outside of intended research applications.